155 related articles for article (PubMed ID: 9114458)
1. Opioid peptides: simultaneous delta agonism and mu antagonism in somatostatin analogues.
Bonner GG; Davis P; Stropova D; Ferguson R; Yamamura HI; Porreca F; Hruby VJ
Peptides; 1997; 18(1):93-100. PubMed ID: 9114458
[TBL] [Abstract][Full Text] [Related]
2. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
3. Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays.
Bonner GG; Davis P; Stropova D; Edsall S; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 2000 Feb; 43(4):569-80. PubMed ID: 10691683
[TBL] [Abstract][Full Text] [Related]
4. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
Budai D; Fields HL
J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
[TBL] [Abstract][Full Text] [Related]
8. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
[TBL] [Abstract][Full Text] [Related]
9. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
10. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Lu Y
Life Sci; 2003 Jun; 73(6):691-8. PubMed ID: 12801590
[TBL] [Abstract][Full Text] [Related]
11. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
12. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors.
Pelton JT; Kazmierski W; Gulya K; Yamamura HI; Hruby VJ
J Med Chem; 1986 Nov; 29(11):2370-5. PubMed ID: 2878079
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.
Misicka A; Lipkowski AW; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
Life Sci; 1997; 60(15):1263-9. PubMed ID: 9096243
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
Rew Y; Malkmus S; Svensson C; Yaksh TL; Chung NN; Schiller PW; Cassel JA; DeHaven RN; Taulane JP; Goodman M
J Med Chem; 2002 Aug; 45(17):3746-54. PubMed ID: 12166947
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of highly mu and delta opioid receptor selective peptides containing a photoaffinity group.
Landis G; Lui G; Shook JE; Yamamura HI; Burks TF; Hruby VJ
J Med Chem; 1989 Mar; 32(3):638-43. PubMed ID: 2537426
[TBL] [Abstract][Full Text] [Related]
19. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
20. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
